Labcorp's Q1 earnings beat expectations, but revenue growth and organic growth trail industry benchmarks.
Lufthansa reports Q1 loss, but reaffirms 2025 profit outlook amid macroeconomic uncertainties and rising costs.
Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.
Labcorp's Q1 earnings beat expectations, but revenue growth and organic growth trail industry benchmarks.
Lufthansa reports Q1 loss, but reaffirms 2025 profit outlook amid macroeconomic uncertainties and rising costs.
Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.